Amrize AG (VTX:AMRZ) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Simply Wall St · 2d ago

Shareholders might have noticed that Amrize AG (VTX:AMRZ) filed its second-quarter result this time last week. The early response was not positive, with shares down 3.9% to CHF38.14 in the past week. The results were positive, with revenue coming in at US$3.5b, beating analyst expectations by 2.9%. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

earnings-and-revenue-growth
SWX:AMRZ Earnings and Revenue Growth August 9th 2026

After the latest results, the 20 analysts covering Amrize are now predicting revenues of US$12.5b in 2026. If met, this would reflect a credible 2.9% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to step up 16% to US$2.58. In the lead-up to this report, the analysts had been modelling revenues of US$12.4b and earnings per share (EPS) of US$2.64 in 2026. The analysts seem to have become a little more negative on the business after the latest results, given the minor downgrade to their earnings per share numbers for next year.

See our latest analysis for Amrize

The consensus price target held steady at CHF49.74, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Amrize analyst has a price target of CHF57.90 per share, while the most pessimistic values it at CHF40.45. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The period to the end of 2026 brings more of the same, according to the analysts, with revenue forecast to display 6.0% growth on an annualised basis. That is in line with its 5.1% annual growth over the past year. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 5.1% annually. It's clear that while Amrize's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Amrize. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Amrize going out to 2028, and you can see them free on our platform here..

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Amrize , and understanding it should be part of your investment process.